title: Second line treatment options in advanced colorectal cancer.
authors.forename: J M
authors.initials: JM
authors.lastname: Stewart
authors.forename: M J
authors.initials: MJ
authors.lastname: Millward
authors.forename: J R
authors.initials: JR
authors.lastname: Zalcberg
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D018432:Drug Resistance, Multiple; D019008:Drug Resistance, Neoplasm; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D016685:Mitomycin / Q000008:administration & dosage; D011799:Quinazolines / Q000008:administration & dosage; D013876:Thiophenes / Q000008:administration & dosage; D013940:Thymidylate Synthase / Q000378:metabolism
chemical_list: D011799:Quinazolines; D013876:Thiophenes; D016685:Mitomycin; D013940:Thymidylate Synthase; C068874:raltitrexed; D005472:Fluorouracil